StockData
Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc. (MTNB) stock

MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)

Close on Nov 18, 2026Market cap $13.37MP/E –Yield –

Matinas BioPharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Matinas BioPharma's market cap was $5.96M on Nov 11, 2026, against $66.38M a year earlier. Over the last 5 years it ranged from $5.96M to $3.28B, with a median of $526.17M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.96M-88.5%
2025Dec 31, 2025$51.87M+33.3%
2024Dec 31, 2024$38.91M-94.5%
2023Dec 29, 2023$704.55M-56.7%
2022Dec 30, 2022$1.63B-50.4%
2021Dec 31, 2021$3.28B-19.3%
2020Dec 31, 2020$4.06B-26.7%
2019Dec 31, 2019$5.54B+535.4%
2018Dec 31, 2018$871.90M-46.1%
2017Dec 29, 2017$1.62B+33.0%
2016Dec 30, 2016$1.22B–

More Matinas BioPharma figures

See a number that looks wrong?